Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015

MarketReserchReports.biz has recently announced the addition of a market study “ Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015 ”

GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q4 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData's proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research

View Report at : http://www.marketresearchreports.biz/analysis/656032

Scope

• Analysis of the market trends for the pharmaceutical industry in the global arena.
• Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
• Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
• Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
• Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
• Analysis of partnership and licensing deals based on clinical stage of development of products.
• Summary of the pharmaceutical deals globally in the five quarters.
• Information on the top deals happened in the pharmaceutical industry.
• Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
• League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs

Download Sample copy of this Report at:

http://www.marketresearchreports.biz/sample/sample/656032

Reasons to buy

• Enhance your decision making capability in a more rapid and time sensitive manner.
• Find out the major deal performing segments for investments in your industry.
• Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
• Identify companies that are aggressively looking to raise capital in the market
• Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
• Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
• Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
• Identify growth segments and opportunities in each region within the industry.
• Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Browse Our Press Releases by Prnewswire: http://www.prnewswire.com/news/marketresearchreports.biz

Table Of Content

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 12

2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2015 16

2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q4 2015 16

2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q4 2015 19

2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q4 2015 20

2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q4 2015 21

2.4.1 Allergan and Pfizer to Combine in USD160 Billion Deal 21

2.4.2 Shire Acquires Dyax 22

2.4.3 AstraZeneca Prices Public Offering of Notes for USD6 Billion 23

2.4.4 Sanofi to Enter into Licensing Agreement with Hanmi Pharma 23

2.4.5 AstraZeneca Acquires 55% Stake in Acerta Pharma 24

\

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz